Independent Conference Highlights of the 2024 CTOS Annual Meeting: Perspectives on Emerging Data in Desmoid Tumors *

Review slidesets, a ClinicalThought commentary, and expert analysis of key data from the 2024 CTOS Annual Meeting.

Share

Program Content

Activities

Desmoid Tumors CTOS 2024 Preview
An Expert’s Guide to CTOS 2024: Preview of the Top Desmoid Tumor Abstracts
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2024

Expires: November 13, 2025

4 Capsule Summaries

Activities

Nirogacestat Real World Data
Retrospective Real-world Study of Nirogacestat in Patients With Desmoid Tumors
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2024

Expires: November 25, 2025

Primary Intraabdominal DF
Multidisciplinary Care of Patients With Primary, Intra-abdominal Desmoid Fibromatosis: A Single-Institution 30-Yr Experience
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2024

Expires: November 25, 2025

DeFi Follow Up
DeFi: Long-term Follow-up of Nirogacestat for Adults With Desmoid Tumors
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2024

Expires: November 25, 2025

DeFi Nirogacestat for Poor Prognosis
DeFi: Subgroup Analysis of Nirogacestat Efficacy in Patients With Desmoid Tumors and Poor Prognostic Factors
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.